The functional status of incidentally discovered bilateral adrenal lesions

Clinical Endocrinology

Volumn 75, Issue 1, 2011, Pages 44-49

  Androulakis, Ioannis I ^a   Kaltsas, Gregory A ^b   Markou, Athina ^a   Tseniklidi, Ermioni ^a   Kafritsa, Paraskevi ^a   Pappa, Theodora ^a   Papanastasiou, Lambrini ^a   Piaditis, George P ^a  

^a G GENNIMATAS GENERAL HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; CHOLESTEROL; CORTICOTROPIN; DEXAMETHASONE; GLUCOSE; HYDROCORTISONE; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; POTASSIUM; PRASTERONE SULFATE; RENIN; SODIUM; SODIUM CHLORIDE; TRIACYLGLYCEROL;

ADRENAL DISEASE; ADRENAL INCIDENTALOMA; ADULT; ALDOSTERONE RELEASE; ARTICLE; BILATERAL ADRENAL LESION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; FEMALE; FUNCTIONAL STATUS; HUMAN; IMAGING; INCIDENTAL FINDING; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; SODIUM BLOOD LEVEL; UNILATERAL ADRENAL INCIDENTALOMA; ADRENAL CORTEX ADENOMA; ADRENAL CORTEX TUMOR; ADRENAL TUMOR; METABOLISM; MIDDLE AGED; PHYSIOLOGY; SECRETION (PROCESS);

ADRENAL CORTEX NEOPLASMS; ADRENAL GLAND NEOPLASMS; ADRENOCORTICAL ADENOMA; ALDOSTERONE; HUMANS; HYDROCORTISONE; INCIDENTAL FINDINGS; INSULIN RESISTANCE; MALE; MIDDLE AGED;

EID: 79958797490     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2011.04013.x     Document Type: Article

References (32)

1. Kloos, R.T., Gross, M.D., Francis, I.R., et al. (1995) Incidentally discovered adrenal masses. Endocrine Reviews, 16, 460-484.
2. Aron, D.C., (2001) The adrenal incidentaloma: disease of modern technology and public health problem. Reviews in Endocrine & Metabolic Disorders, 2, 335-342. (Pubitemid 33640582)
3. Mansmann, G., Lau, J., Balk, E., et al. (2004) The clinically inapparent adrenal mass: update in diagnosis and management. Endocrine Reviews, 25, 309-340. (Pubitemid 38528713)
4. Barzon, L., Scaroni, C., Sonino, N., et al. (1998) Incidentally discovered adrenal tumors: endocrine and scintigraphic correlates. Journal of Clinical Endocrinology & Metabolism, 83, 55-62. (Pubitemid 28498310)
5. Barzon, L., Sonino, N., Fallo, F., et al. (2003) Prevalence and natural history of adrenal incidentalomas. European Journal of Endocrinology, 149, 273-285. (Pubitemid 37304697)
6. Bovio, S., Cataldi, A., Reimondo, G., et al. (2006) Prevalence of adrenal incidentaloma in a contemporary computerized tomography series. Journal of Endocrinological Investigation, 29, 298-302. (Pubitemid 43905318)
7. Hedeland, H., Ostberg, G., &, Hokfelt, B., (1968) On the prevalence of adrenocortical adenomas in an autopsy material in relation to hypertension and diabetes. Acta Medica Scandinavica, 184, 211-214.
8. Lacroix, A., &, Bourdeau, I., (2005) Bilateral adrenal Cushing's syndrome: macronodular adrenal hyperplasia and primary pigmented nodular adrenocortical disease. Endocrinology Metabolism Clinics of North America, 34, 441-458. (Pubitemid 40602731)
9. Bernini, G., Moretti, A., Iacconi, P., et al. (2003) Anthropometric, haemodynamic, humoral and hormonal evaluation in patients with incidental adrenocortical adenomas before and after surgery. European Journal of Endocrinology, 148, 213-219. (Pubitemid 36305687)
10. Mantero, F., Terzolo, M., Arnaldi, G., et al. (2000) A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. The Journal of Clinical Endocrinology and Metabolism, 85, 637-644.
11. Terzolo, M., Pia, A., Ali, A., et al. (2002) Adrenal incidentaloma: a new cause of the metabolic syndrome? The Journal of Clinical Endocrinology and Metabolism, 87, 998-1003. (Pubitemid 36121054)
12. Piaditis, G.P., Kaltsas, G.A., Androulakis, I.I., et al. (2009) High prevalence of autonomous cortisol and aldosterone secretion from adrenal adenomas. Clinical Endocrinology (Oxf), 71, 772-778.
13. Nieman, L.K., Biller, B.M., Findling, J.W., et al. (2008) The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism, 93, 1526-1540. (Pubitemid 351656485)
14. Bergman, R.N., Prager, R., Volund, A., et al. (1987) Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. The Journal of Clinical Investigation, 79, 790-800. (Pubitemid 17050904)
15. Matsuda, M., &, DeFronzo, R.A., (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care, 22, 1462-1470. (Pubitemid 29418240)
16. Tsagarakis, S., Kokkoris, P., Roboti, C., et al. (1998) The low-dose dexamethasone suppression test in patients with adrenal incidentalomas: comparisons with clinically euadrenal subjects and patients with Cushing's syndrome. Clinical Endocrinology (Oxf), 48, 627-633. (Pubitemid 28253000)
17. Reincke, M., (2000) Subclinical Cushing's syndrome. Endocrinology Metabolism Clinics of North America, 29, 43-56. (Pubitemid 30151888)
18. Rossi, R., Tauchmanova, L., Luciano, A., et al. (2000) Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features. The Journal of Clinical Endocrinology and Metabolism, 85, 1440-1448. (Pubitemid 32289484)
19. Tauchmanova, L., Rossi, R., Biondi, B., et al. (2002) Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk. The Journal of Clinical Endocrinology and Metabolism, 87, 4872-4878. (Pubitemid 35316318)
20. Terzolo, M., Bovio, S., Reimondo, G., et al. (2005) Subclinical Cushing's syndrome in adrenal incidentalomas. Endocrinology Metabolism Clinics of North America, 34, 423-439. (Pubitemid 40602730)
21. Pivonello, R., De Martino, M.C., De, L.M., et al. (2008) Cushing's syndrome. Endocrinology Metabolism Clinics of North America, 37, 135-149.
22. Allolio, B., &, Fassnacht, M., (2006) Clinical review: adrenocortical carcinoma: clinical update. Journal of Clinical Endocrinology & Metabolism, 91, 2027-2037. (Pubitemid 43854976)
23. Christopoulos, S., Bourdeau, I., &, Lacroix, A., (2005) Clinical and subclinical ACTH-independent macronodular adrenal hyperplasia and aberrant hormone receptors. Hormone Research, 64, 119-131. (Pubitemid 41507294)
24. Lampron, A., Bourdeau, I., Oble, S., et al. (2009) Regulation of aldosterone secretion by several aberrant receptors including for glucose-dependent insulinotropic peptide in a patient with an aldosteronoma. Journal of Clinical Endocrinology & Metabolism, 94, 750-756.
25. Reznik, Y., Lefebvre, H., Rohmer, V., et al. (2004) Aberrant adrenal sensitivity to multiple ligands in unilateral incidentaloma with subclinical autonomous cortisol hypersecretion: a prospective clinical study. Clinical Endocrinology (Oxf), 61, 311-319. (Pubitemid 39287059)
26. Walker, B.R., (2007) Glucocorticoids and cardiovascular disease. European Journal of Endocrinology, 157, 545-559. (Pubitemid 350187371)
27. Rossi, G., Boscaro, M., Ronconi, V., et al. (2005) Aldosterone as a cardiovascular risk factor. Trends in Endocrinology and Metabolism, 16, 104-107. (Pubitemid 40432459)
28. Tanaka, M., Izeki, M., Miyazaki, Y., et al. (2002) Combined primary aldosteronism and Cushing's syndrome due to a single adrenocortical adenoma complicated by Hashimoto's thyroiditis. Internal Medicine, 41, 967-971. (Pubitemid 35423079)
29. Honda, T., Nakamura, T., Saito, Y., et al. (2001) Combined primary aldosteronism and preclinical Cushing's syndrome: an unusual case presentation of adrenal adenoma. Hypertension Research, 24, 723-726. (Pubitemid 33133788)
30. Nawar, R., &, Aron, D., (2005) Adrenal incidentalomas-a continuing management dilemma. Endocrine-Related Cancer, 12, 585-598. (Pubitemid 41482994)
31. Young Jr, W.F., (2007) Clinical practice. The incidentally discovered adrenal mass. The New England Journal of Medicine, 356, 601-610. (Pubitemid 46220820)
32. NIH state-of-the-science statement on management of the clinically inapparent adrenal mass ("incidentaloma"). (2002) NIH consensus and state-of-the-science statements, 19, 1-25.